BIVALIRUDIN INJECTION
Google image searchProduct monograph
Active ingredient
bivalirudin, 5 MG/ML
DIN: 02505517
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE
Schedule: Prescription
Company: AVIR PHARMA INC.
Date: 05-MAR-2021
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AE — Direct thrombin inhibitors (ATC, ATC/DDD)
- B01AE06 — BIVALIRUDIN (ATC/DDD)
Reference brand drug: Angiomax
